← Back to Search

Procedure

Bilateral Cochlear Implant Users for Hearing Loss

N/A
Waitlist Available
Led By Joshua G. Bernstein, PhD
Research Sponsored by University of Maryland, College Park
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-treatment - after at least 6 months use of a cochlear implant if ci user. not collected for non-implanted listeners with acoustic hearing.
Awards & highlights

Study Summary

"This trial looks at how cochlear implants help people with severe hearing loss. They are studying people with implants in both ears and those with an implant in one ear and good hearing in the other. They

Who is the study for?
This trial is for individuals with severe to profound hearing loss who are using cochlear implants (CIs). It's specifically aimed at those with bilateral CIs (one on each ear) or single-sided deafness (SSD), where one CI is used alongside normal hearing in the other ear. Participants should be able to undergo diagnostic tests, CT imaging, and targeted aural rehabilitation.Check my eligibility
What is being tested?
The study measures how differences in auditory input between two ears affect speech understanding and spatial hearing in CI users. It involves diagnostic tests of CI function, electrophysiological measures of auditory health, CT imaging for CI placement assessment, and aural rehabilitation to see if training can improve performance.See study design
What are the potential side effects?
While this trial does not involve medication that typically has side effects, participants may experience discomfort from diagnostic procedures or fatigue during aural rehabilitation sessions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-treatment - after at least 6 months use of a cochlear implant if ci user. not collected for non-implanted listeners with acoustic hearing.
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-treatment - after at least 6 months use of a cochlear implant if ci user. not collected for non-implanted listeners with acoustic hearing. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Computed-tomography scan
Electrically evoked compound action potentials (ECAPs)
Electrode impedance (transelectrode impedance matrix)
+2 more
Secondary outcome measures
Perceptual Fusion
Sound Localization
Spectrotemporal ripple sensitivity

Trial Design

3Treatment groups
Experimental Treatment
Group I: Unilateral Cochlear Implant Users with Single-Sided DeafnessExperimental Treatment2 Interventions
Group II: Non-Implanted Listeners with Acoustic HearingExperimental Treatment1 Intervention
Group III: Bilateral Cochlear Implant UsersExperimental Treatment2 Interventions

Find a Location

Who is running the clinical trial?

National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
330 Previous Clinical Trials
178,171 Total Patients Enrolled
56 Trials studying Hearing Loss
19,853 Patients Enrolled for Hearing Loss
University of Maryland, College ParkLead Sponsor
155 Previous Clinical Trials
45,365 Total Patients Enrolled
2 Trials studying Hearing Loss
300 Patients Enrolled for Hearing Loss
Vanderbilt UniversityOTHER
704 Previous Clinical Trials
6,143,063 Total Patients Enrolled
9 Trials studying Hearing Loss
1,158 Patients Enrolled for Hearing Loss

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the clinical trial open to participants aged 60 and above?

"Candidates must be aged 18 at least and no older than 85 to qualify for this research project."

Answered by AI

Which individuals meet the eligibility criteria to partake in this research investigation?

"Individuals aged between 18 and 85 with documented hearing impairment are eligible to enroll in this study, which aims to recruit approximately 300 participants."

Answered by AI

Are new participants currently being accepted for this ongoing medical study?

"Per clinicaltrials.gov, this particular study is not presently accepting new participants. Originally listed on 12/19/2023 and last modified on 3/1/2024, it has concluded recruitment. However, there are currently 173 other ongoing trials actively seeking candidates for enrollment."

Answered by AI
~200 spots leftby May 2028